Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Dec 8;14(5):769–772. doi: 10.1016/j.cgh.2015.12.007

Table 2.

ORs and 95% CIs for associations between coffee and tea consumption and BE

Controls
(n=1728)
N
BE
(n=310)
N
Crude
OR (95% CI)
Adjusted
ORa (95% CI)
Non-coffee drinker 510 71 Referent Referent
Ever coffee drinkers 1218 239 1.41 (1.06-1.87) 1.04 (0.76-1.42)
Caffeinated
(drinks/day)
0-<1 88 14 1.14 (0.62-2.12) 1.19 (0.62-2.28)
1-<2 280 33 0.85 (0.55-1.31) 0.73 (0.46-1.17)
2-<3 327 66 1.45 (1.01-2.08) 1.07 (0.72-1.59)
3-<4 219 54 1.77 (1.20-2.61) 1.11 (0.72-1.70)
≥4 130 38 2.10 (1.35-3.26) 1.22 (0.76-1.98)
P-trend in coffee drinkers 0.002 0.30
Decaffeinated
(drinks/day)
0-<1 27 3 0.80 (0.24-2.70) 0.74 (0.21-2.65)
≥1 85 16 1.35 (0.75-2.44) 1.20 (0.63-2.30)
Coffee strength
Weak 53 8 1.08 (0.50-2.37) 0.77 (0.34-1.75)
Medium 771 146 1.36 (1.00-1.85) 1.01 (0.72-1.41)
Strong 324 76 1.69 (1.19-2.40) 1.18 (0.80-1.73)
Coffee temperature
Cold 6 2 2.39 (0.47-12.1) 1.63 (0.30-9.01)
Warm 156 26 1.20 (0.74-1.94) 0.90 (0.54-1.50)
Hot or extremely hot 1028 210 1.47 (1.10-1.96) 1.08 (0.79-1.49)
Non-tea drinker 850 130 Referent Referent
Ever tea drinkers 878 180 1.34 (1.05-1.71) 1.11 (0.85-1.44)
Caffeinated tea
(drinks/day)
0-<1 356 80 1.47 (1.08-1.99) 1.25 (0.90-1.73)
1-<2 189 44 1.52 (1.05-2.22) 1.18 (0.79-1.76)
≥2 149 28 1.23 (0.79-1.92) 0.88 (0.55-1.40)
P-trend in tea drinkers 0.45 0.14
Decaffeinated tea
Ever 30 5 1.09 (0.42-2.86) 0.66 (0.23-1.87)
Green tea
Ever 85 13 1.00 (0.54-1.84) 1.10 (0.57-2.11)
Tea temperature
Cold 724 160 1.45 (1.12-1.86) 1.13 (0.86-1.48)
Warm 24 1 0.27 (0.04-2.03) 0.45 (0.06-3.53)
Hot or extremely hot 116 18 1.02 (0.60-1.72) 1.09 (0.62-1.91)
a

Adjusted for age, sex, race, WHR, GERD symptoms, smoking, alcohol use, H pylori infection, use of aspirin/NSAIDs, PPIs/H2RAs, and recruitment source.